|
🐜
|
EULAR recommendations for the management of Behçet disease
16 auth.
G. Hatemi,
A. Silman,
D. Bang,
B. Bodaghi,
A. Chamberlain,
A. Gül,
M. Houman,
I. Kötter,
I. Olivieri,
C. Salvarani,
...
P. Sfikakis,
A. Siva,
M. Stanford,
N. Stübiger,
S. Yurdakul,
H. Yazici
|
9 |
2008 |
9
🐜
|
|
🐬
|
Behçet's disease: Ocular effects and treatment
C. Deuter,
I. Kötter,
G. Wallace,
P. Murray,
N. Stübiger,
M. Zierhut
|
7 |
2008 |
7
🐬
|
|
🐜
|
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease
16 auth.
G. Hatemi,
A. Silman,
D. Bang,
B. Bodaghi,
A. Chamberlain,
A. Gül,
M. Houman,
I. Kötter,
I. Olivieri,
C. Salvarani,
...
P. Sfikakis,
A. Siva,
M. Stanford,
N. Stübiger,
S. Yurdakul,
H. Yazıcı
|
7 |
2008 |
7
🐜
|
|
🐢
|
The use of interferon α in behçet disease: review of the literature
I. Kötter,
I. Günaydın,
M. Zierhut,
N. Stübiger
|
7 |
2004 |
7
🐢
|
|
🐬
|
Treatment of ocular symptoms of Behçet’s disease with interferon α2a: a pilot study
I. Kötter,
A. Eckstein,
N. Stübiger,
M. Zierhut
|
6 |
1998 |
6
🐬
|
|
🐜
|
CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications—results of a retrospective analysis of 117 cases
7 auth.
I. Kötter,
I. Günaydın,
M. Batra,
R. Vonthein,
N. Stübiger,
G. Fierlbeck,
...
A. Melms
|
6 |
2006 |
6
🐜
|
|
🐢
|
Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial.
10 auth.
I. Kötter,
R. Vonthein,
M. Zierhut,
A. Eckstein,
T. Ness,
I. Günaydın,
...
B. Grimbacher,
S. Blaschke,
H. Peter,
N. Stübiger
|
6 |
2004 |
6
🐢
|
|
🐢
|
The use of interferon alpha in Behçet disease: review of the literature.
I. Kötter,
I. Günaydın,
M. Zierhut,
N. Stübiger
|
6 |
2004 |
6
🐢
|
|
🐬
|
Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis
K. Siepmann,
M. Huber,
N. Stübiger,
C. Deuter,
M. Zierhut
|
6 |
2004 |
6
🐬
|
|
🐜
|
Ocular inflammatory events following COVID-19 vaccination: a multinational case series
51 auth.
Ilaria Testi,
C. Brandão-de-Resende,
Rupesh Agrawal,
C. Pavesio,
L. Steeples,
Balini Balasubramaniam,
P. McCluskey,
F. Pichi,
A. Agarwal,
C. Herbort,
L. Cimino,
Salam Iriqat,
J. Thorne,
Jose J. Echegaray,
K. Babu,
...
A. Bialasiewicz,
D. Goldstein,
N. Ghadiri,
A. Fonollosa Calduch,
G. Andrade,
P. Mahendradas,
J. González-López,
E. Carreño,
R. Hamam,
N. Stübiger,
B. Bodaghi,
Yu-Jang Chao,
M. Takeuchi,
M. Tay-Kearney,
A. Portero,
H. Keino,
M. Esteban-Ortega,
Joanna Przeździecka-Dołyk,
A. Radosavljević,
I. Paredes,
Rupesh Agrawal,
H. Ling,
Wei Kiong,
M. Tien,
Xin Le Ng,
C. Pavesio,
Ilaria Testi,
S. Chee,
J. Siak,
Inés Hernanz-Rodríguez,
V. Menezo,
C. Tappeiner,
F. Cruz,
P. Addison,
R. Kuijpers,
D. Vasconcelos-Santos
|
6 |
2021 |
6
🐜
|
